(Q37474072)

20 August 2017

1 reference

title

Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases (English)

1 reference

20 August 2017

0 references

11

Bernard Combe

1 reference

20 August 2017

author name string

Claire Immediato Daïen

1

1 reference

20 August 2017

Agnes Monnier

2

1 reference

20 August 2017

Pascal Claudepierre

3

1 reference

20 August 2017

Arnaud Constantin

4

1 reference

20 August 2017

Jean-Paul Eschard

5

1 reference

20 August 2017

Eric Houvenagel

6

1 reference

20 August 2017

Mahtab Samimi

7

1 reference

20 August 2017

Stephan Pavy

8

1 reference

20 August 2017

Edouard Pertuiset

9

1 reference

20 August 2017

Eric Toussirot

10

1 reference

20 August 2017

Jacques Morel

12

1 reference

20 August 2017

Club Rhumatismes et Inflammation (CRI)

13

1 reference

20 August 2017

publication date

7 May 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

48

1 reference

20 August 2017

issue

8

1 reference

20 August 2017

page(s)

883-886

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

20 August 2017

1 reference

Effectiveness of infliximab in treating selected patients with sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

Treatment of sarcoidosis with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

Development of sarcoidosis during etanercept therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

Pulmonary granulomas after tumour necrosis factor alpha antagonist therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

Lung injury linked to etanercept therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

Pulmonary intestinal-type adenocarcinoma does not show enteric differentiation by immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

Tumor necrosis factor antagonists: different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

Etanercept plus standard therapy for Wegener's granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

The utility of tumour necrosis factor blockade in orphan diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

Up regulation of the production of tumour necrosis factor alpha and interferon gamma by T cells in ankylosing spondylitis during treatment with etanercept

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

Effect of treatment of rheumatoid arthritis with infliximab on IFN gamma, IL4, T-bet, and GATA-3 expression: link with improvement of systemic inflammation and disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

Pulmonary sarcoidosis developing during infliximab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP046

10.1093/RHEUMATOLOGY/KEP046

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference